Document is current

Any future updates will be listed below

Reduced toxicity, myeloablative HLA-haploidentical hematopoietic stem cell transplantation with post-transplantation cyclophosphamide for sickle cell disease

Crossref DOI link: https://doi.org/10.1007/s00277-017-3030-x

Published Online: 2017-06-01

Published Print: 2017-08

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark